Literature DB >> 7782173

Role of anaerobic bacteria in chronic otitis media and cholesteatoma.

I Brook1.   

Abstract

Otitis media (OM), a common infection in children, can cause significant morbidity. Selection of the most appropriate treatment regimen directed against the pathogens responsible for the OM can minimize complications. The most frequently isolated bacteria from chronic OM are Staphylococcus aureus, Pseudomonas aeruginosa and anaerobic bacteria. The predominant anaerobes are Peptostreptococcus spp., pigmented Prevotella and Porphyromonas spp., Bacteroides spp. and Fusobacterium spp. Many of the organisms causing OM can produce beta-lactamase, which can contribute to the failure of penicillins therapy. The appropriate surgical and medical therapy for chronic OM is reviewed.

Entities:  

Mesh:

Year:  1995        PMID: 7782173     DOI: 10.1016/0165-5876(94)01080-h

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Complications of Acute Otitis Media and Sinusitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

2.  Fusobacterial infections in children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

3.  First isolation of Bacteroides thetaiotaomicron from a patient with a cholesteatoma and experiencing meningitis.

Authors:  Lionel Feuillet; Joseph Carvajal; Isabelle Sudre; Jean Pelletier; Jean Marc Thomassin; Michel Drancourt; André Ali Cherif
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 4.  Infectious causes of cholesteatoma and treatment of infected ossicles prior to reimplantation by hydrostatic high-pressure inactivation.

Authors:  Wycliffe Omurwa Masanta; Rebecca Hinz; Andreas Erich Zautner
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

5.  Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media.

Authors:  Daniel N Frank; Jose Pedrito M Magno; Karen Joyce S Velasco; Tori C Bootpetch; Jacob Ephraim D Salud; Kevin Jer V David; Aaron L Miller; Eljohn C Yee; Heather P Dulnuan; Richard B Pyles; Jan Alexeis C Lacuata; Jeric L Arbizo; Jennifer M Kofonow; Beatrice Guce; Kevin Michael D Mendoza; Charles E Robertson; Gabriel Martin S Ilustre; Alessandra Nadine E Chiong; Shi-Long Lu; Erik A Tongol; Nicole D Sacayan; Talitha Karisse L Yarza; Charlotte M Chiong; Regie Lyn P Santos-Cortez
Journal:  Front Cell Infect Microbiol       Date:  2022-04-19       Impact factor: 6.073

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.